Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medical University of Vienna
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patient has received a kidney transplantation
full SARS-CoV-2 vaccination with mRNA vaccine (two doses) at least 4 weeks before screening
\> 18 years of age
no SARS-CoV-2 spike protein antibodies at least 4 weeks after the second dose of an mRNA vaccine
You may not be if
acute illness with fever
Prior documented infection with SARS-CoV-2
triple anticoagulation therapy
Subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s)
Subject has known sensitivity or intolerance to any of the products to be administered for the purpose of this study
Subject has any kind of disorder that compromises the ability of the subject to give written informed consent and/or to comply with the study procedures
Subject is pregnant or breast feeding
Clareo Health | Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients
